Levels of cyclin d1 and d3 in malignant melanoma: Deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma

Clinical Cancer Research

Volumn 6, Issue 9, 2000, Pages 3614-3620

  Florenes, V A ^a   Faye, R S ^a   Maelandsmo, G M ^a   Nesland, J M ^a   Holm, R ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN D3; KI 67 ANTIGEN;

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

CELL CYCLE; CELL DIVISION; CYCLIN A; CYCLIN D1; CYCLINS; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MELANOMA; NEVUS; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033822962     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. The retinoblastoma protein pathway and the restriction point
2. Cancer cell cycles
3. Cyclin D1/PRAD1 as a central target in oncogenesis
4. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age
5. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis
6. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas
7. Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer
8. Expression of cyclin D1 correlates with malignancy in human ovarian tumours
9. Prognostic value of p27(Kip1) and cyclin D1 expression in esophageal cancer
10. Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21(WAF1)/(CIP1) in gastric cancer
11. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value
12. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer
13. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus
14. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis
15. Amplification of cyclin genes in colorectal carcinomas
16. 1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation
17. 1/S phase transition in fibroblasts
18. D-type cyclins in adult human testis and testicular cancer: Relation to cell type, proliferation, differentiation, and malignancy
19. Cyclin D3 expression in normal, reactive and neoplastic tissues
20. Cyclin kinase inhibitor p21(WAF1)/(CIP1) in malignant melanoma: Reduced expression in metastatic lesions
21. Protein expression of the cell-cycle inhibitor p27(Kip1) in malignant melanoma: Inverse correlation with disease-free survival
22. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast
23. Determination of the prognostic value of cyclin D1 overexpression in breast cancer
24. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer
25. Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast
26. Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis
27. Cyclin D1 overexpression in invasive breast cancers: Correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity
28. CDK-independent activation of estrogen receptor by cyclin D1
29. Estrogen receptor mediated inhibition of cancer cell invasion and motility: An overview
30. 1 cyclins in senescent human diploid fibroblasts: Accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes
31. Cyclin D1 is an essential mediator of apoptotic neuronal cell death
32. Cyclin D1 and p16(INK4A) expression predict reduced survival in carcinoma of the anterior tongue